The 2% device growth in the US should be read within the context the US market is at a more mature stage and shifting towards the Software-as-a-Service revenue market represented by a much stronger 23% growth in the Masks and other category. This is a positive move towards the SAAS category?
Ann: ResMed Announces Results for the First Quarter of FY2024, page-30
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$35.59 |
Change
-0.330(0.92%) |
Mkt cap ! $21.82B | |||
| Open | High | Low | Value | Volume |
| $35.74 | $35.87 | $35.59 | $21.77M | 610.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 621 | $35.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $35.70 | 35 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| RMD (ASX) Chart |